Clinical Trials List
2022-04-05 - 2024-07-31
Phase I/II
Terminated5
ICD-10C30.0
Malignant neoplasm of nasal cavity
ICD-10Z51.12
Encounter for antineoplastic immunotherapy
ICD-9160.0
Malignant neoplasm of nasal cavities
-
Trial Applicant
MEDPACE TAIWAN LIMITED
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2026/02/01
Investigators and Locations
Co-Principal Investigator
- Chi-Lu Chiang Division of Thoracic Medicine
- Hsu-ching Huang Division of Thoracic Medicine
- Chia-I Shen Division of Thoracic Medicine
- 趙恒勝 Division of Thoracic Medicine
- 許志堅 Division of Ophthalmology
- Yung-Hung Luo Division of Thoracic Medicine
- YEN-HAN TSENG Division of Thoracic Medicine
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
- 李柏昕 Division of Thoracic Medicine
- KUO-HSUAN HSU Division of Thoracic Medicine
- JENG-SEN TSENG Division of Thoracic Medicine
- YEN-HSIANG HUANG Division of Thoracic Medicine
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
- 吳尚俊 Division of General Internal Medicine
- YEN-TING LIN Division of General Internal Medicine
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
- Chong-Jen Yu Division of General Internal Medicine
- 徐偉勛 醫學研究部
- 廖唯昱 Division of General Internal Medicine
- Jih-Hsiang Lee Division of Hematology & Oncology
- 許嘉林 Division of General Internal Medicine
- 廖斌志 Division of Hematology & Oncology
- James Chih-Hsin Yang Division of Hematology & Oncology
- 蔡子修 Division of General Internal Medicine
- CHAO-CHI HO CHAO-CHI HO Division of General Internal Medicine
- JIN-YUAN SHIH Division of General Internal Medicine
- 楊景堯 Division of General Internal Medicine
- 魏以宣 Division of Ophthalmology
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
- Chih-Liang Wang Division of Hematology & Oncology
- 林定佑 Division of Hematology & Oncology
- Wen-Cheng Chang Division of Hematology & Oncology
- Chien-Ying Liu Division of Hematology & Oncology
- 吳教恩 Division of Hematology & Oncology
- 邱立忠 Division of Hematology & Oncology
- Chih-Hsi Kuo Division of Hematology & Oncology
- Ching-His Siao Division of Ophthalmology
- Shih-Hong Li Division of Hematology & Oncology
- 柯皓文 Division of Hematology & Oncology
- Chih-Hung Chen Division of Hematology & Oncology
- 枋岳甫 Division of Hematology & Oncology
- Ping-Chih Hsu Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Terminated
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
16 participants
-
Global
332 participants
